TITLE

Clinical implications of CIP2A protein expression in breast cancer

AUTHOR(S)
Yu, Guangzhe; Liu, Guohong; Dong, Juan; Jin, Yingyu
PUB. DATE
June 2013
SOURCE
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
87820212

 

Related Articles

  • Expression and clinical significance of p53 and autophagy-related gene Beclin1 in salivary pleomorphic adenoma and carcinoma in pleomorphic adenoma. CHEN Guo-kun; WU Yi-hua; ZHANG Shi-zhou; ZHANG Dong-sheng; HUANG Sheng-yun; WEN Jie // Shanghai Journal of Stomatology;Apr2014, Vol. 23 Issue 2, p214 

    PURPOSE: To investigate the expression of p53 and Beclin1 in salivary pleomorphic adenoma (PA) and its clinical significance. METHODS: The expression of p53 and Beclin1 were assessed by immunohistochemistry in 108 cases of PA and 20 cases of carcinoma in pleomorphic adenoma (CIPA). The results...

  • Lipase member H is a novel secreted protein associated with a poor prognosis for breast cancer patients. Cui, Meizi; Jin, Haofan; Shi, Xiumin; Qu, Ge; Liu, Lidi; Ding, Xiaobo; Wang, Yanbo; Niu, Chao // Tumor Biology;Nov2014, Vol. 35 Issue 11, p11461 

    The objective of this study is to identify the expression status and clinical implications of lipase member H (LIPH) in breast cancer in order to develop strategies for breast cancer management. LIPH expression status was detected in 346 breast cancer specimens by immunohistochemistry. The...

  • DEK: A novel early screening and prognostic marker for breast cancer. GUO YING; YONGHUI WU // Molecular Medicine Reports;2015, Vol. 12 Issue 5, p7491 

    The present study aimed to investigate the expression status and clinical implications of DEK in breast cancer, in order to contribute to developments in breast cancer management. DEK expression status was detected in 628 breast cancer specimens by western blot analysis and immunohistochemistry...

  • CD74: a potential novel target for triple-negative breast cancer. Tian, Buxian; Zhang, Yuhong; Li, Nan; Liu, Xuewen; Dong, Jianfeng // Tumor Biology;Dec2012, Vol. 33 Issue 6, p2273 

    The expression status of CD74 in breast cancer stem cells and its clinical implications was evaluated in order to lay a foundation for managing breast cancer. Five hundred and eighty breast cancer specimens were enrolled in the study. The relationship between the CD74 protein and...

  • Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer. Roylance, Rebecca; Endesfelder, David; Jamal-Hanjani, Mariam; Burrell, Rebecca; Gorman, Patricia; Sander, Jil; Murphy, Niamh; Birkbak, Nicolai; Hanby, Andrew; Speirs, Valerie; Johnston, Stephen; Kschischo, Maik; Swanton, Charles // Breast Cancer Research & Treatment;Nov2014, Vol. 148 Issue 1, p221 

    Regulators of transition through mitosis such as SURVIVIN and Aurora kinase A (AURKA) have been previously implicated in the initiation of chromosomal instability (CIN), a driver of intratumour heterogeneity. We investigate the relationship between protein expression of these genes and directly...

  • Implications of Functional Proteomics in Breast Cancer. Chae, Young Kwang; Gonzalez‐Angulo, Ana Maria // Oncologist;2014, Vol. 19 Issue 4, p328 

    Breast cancer is one of the major public health problems of the Western world. Recent advances in genomics and gene expression-profiling approaches have enriched our understanding of this heterogeneous disease. However, progress in functional proteomics in breast cancer research has been...

  • TGF-β1 and BRCA2 Expression are Associated with Clinical Factors in Breast Cancer. Junchuan Li; Hongyu Zhu; Tingxuan Chen; Guihua Dai; Lanying Zou // Cell Biochemistry & Biophysics;Jul2011, Vol. 60 Issue 3, p245 

    The objective of this study was to investigate the possible association between the expression of transforming growth factor beta-1 (TGF-β1) and breast cancer type2 susceptibility protein (BRCA2) with clinical factors in breast cancer. TGF-β1, BRCA2, human epidermal growth factor receptor2...

  • The clinical and prognostic significance of midkine in breast cancer patients. Li, Fuguang; Tian, Peijun; Zhang, Jun; Kou, Changyuan // Tumor Biology;Dec2015, Vol. 36 Issue 12, p9789 

    Midkine overexpression has been shown to be a tumor biomarker in several types of human cancer, but little is known about the clinical significance of midkine in breast cancer patients. The aim of this study was to analyze the expression of midkine in breast cancer and its correlation with...

  • Axl receptor tyrosine kinase expression in breast cancer. D'Alfonso, Timothy M.; Hannah, Jeffrey; Zhengming Chen; Yifang Liu; Pengbo Zhou; Shin, Sandra J. // Journal of Clinical Pathology;Aug2014, Vol. 67 Issue 8, p690 

    Aims Triple-negative breast cancer comprises a clinically aggressive group of invasive carcinomas. We examined a published gene expression screen of a panel of breast cancer cell lines to identify a potential triple-negative breast cancer-specific gene signature, and attempted to verify our...

  • Girdin protein: a new potential distant metastasis predictor of breast cancer. Liu, Caigang; Zhang, Yanjun; Xu, Hong; Zhang, Ruishan; Li, Hua; Lu, Ping; Jin, Feng // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1554 

    To investigate the expression status and the clinical implications of Girdin protein in breast cancer. The expression status of Girdin protein and clinicopathological parameters in 820 breast cancer specimens was analyzed using immunohistochemistry staining and the relationship between Girdin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics